02:41 AM EDT, 10/07/2026 (MT Newswires) -- Dr. Martens (DOCS.L) has adopted a new market-based reporting structure, which took effect April 1, according to a Wednesday filing. Under the new structure, the footwear manufacturer will report results across its US and Global Markets segments. Corporate overhead and functional costs will not be allocated to either segment and will instead be reported separately under Central as an unallocated reconciling item.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.